This information is intended for Colorado Prescribers
HB 19-1131
| MARKETED PRESCRIPTION DRUG | COLORADO WAC DISCLOSURE FORM | DATE UPDATED |
|---|---|---|
| Diabetes Products | Form | 1/17/2020 |
| Vaccines | Form | 1/17/2020 |
| ALDURAZYME® (laronidase) | Form | 1/22/2020 |
| ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein] | Form | 1/17/2020 |
| AUBAGIO® (teriflunomide) | Form | 1/17/2020 |
| AVALIDE® (irbesartan/hydrochlorothiazide) | Form | 1/17/2020 |
| AVAPRO® (irbesartan) | Form | 1/17/2020 |
| CABLIVI® (caplacizumab-yhdp) | Form | 1/17/2020 |
| CAPRELSA® (vandetanib) | Form | 1/17/2020 |
| CERDELGA® (eliglustat) capsules, for oral use | Form | 1/17/2020 |
| Cerezyme® (imiglucerase for injection) | Form | 1/17/2020 |
| DUPIXENT® (dupilumab) Injection | Form | 1/17/2020 |
| ELITEK® (rasburicase) for injection | Form | 1/17/2020 |
| ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] | Form | 1/17/2020 |
| FABRAZYME® (agalsidase beta) for injection, for intravenous use | Form | 1/17/2020 |
| JEVTANA® (cabazitaxel) Injection | Form | 1/17/2020 |
| KEVZARA® (sarilumab) | Form | 1/17/2020 |
| LEMTRADA® (alemtuzumab) | Form | 1/17/2020 |
| LIBTAYO® (cemiplimab - rwlc) | Form | 1/17/2020 |
| LUMIZYME® (alglucosidase alfa) | Form | 1/17/2020 |
| Mozobil® (plerixafor injection) | Form | 1/17/2020 |
| MULTAQ® (dronedarone) | Form | 1/17/2020 |
| SARCLISA® (isatuximab-irfc) injection | Form | 3/09/2020 |
| Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] | Form | 1/17/2020 |
| THYROGEN® (thyrotropin alfa for injection) | Form | 1/17/2020 |
| ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion | Form | 1/17/2020 |
House Bill 19-1131. Published by the General Assembly of the State of Colorado
Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Aubagio, Avalide, Avapro, Caprelsa, Elitek, Jevtana, Kevzara, Lemtrada, Lumizyme, Multaq, Thymoglobulin, Zaltrap